Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.

Source:http://linkedlifedata.com/resource/pubmed/id/16551486

Vaccine 2006 May 8 24 19 4122-9

Download in:

View as

General Info

PMID
16551486